Vertex Pharmaceuticals (VRTX)
$558.88 +3.50% Close Oct 30, 2026 Live
Vertex Pharmaceuticals stock today
Vertex Pharmaceuticals closed at $558.88 on October 30, 2026, up 3.50% on the day. Over the past year it returned +33.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $142 billion.
$400.00$450.00$500.00$550.00
NovJan 2026MarMayJulSep
| Period | VRTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +6.9% | -0.9% |
| 3 months | +16.0% | +2.1% |
| Year to date | +23.3% | +11.7% |
| 1 year | +33.1% | +12.4% |
| 3 years | +56.4% | +88.5% |
| 5 years | +202.2% | +76.0% |
Key statistics
- Market value
- $142B
- P/E (trailing)
- 32.6
- Forward P/E
- 28.6
- Price / sales
- 11.3
- 52-week range
- $409.47 to $558.88
- Next report
- Nov 2, 2026
About Vertex Pharmaceuticals
Biopharmaceutical company developing and commercializing medicines for cystic fibrosis and other diseases.
Sector: Health Care · Industry: Biotechnology
More on Vertex Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +9% in the year to Dec 2025
- Valuation: P/E history and peersP/E 32.6, median 26.8 at its last 8 year ends
- Returns: what $1,000 became$1,000 ten years ago is $7,204 today
No forecast, no recommendation. This page describes Vertex Pharmaceuticals from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.